K

Management of Aquagenic Pruritis in Polycythemia Vera

By Krisstina Gowin 3 Videos
0 views
November 6, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

08:18
Insights from 2023 ASH Annual Meeting

Treatment Strategies for Hematocrit Control in PV

Feat. A. Zhou

Featured Video

01:29
Incyte

Targeting CSF-1R to Manage Inflammation and Fibrosis in GVHD

Recommended

AUTOPLAY
24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi
24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi
23:35
University of Colorado Division of Hematology

2024 Updates in PV/ET

Feat. B. McMahon
24:27
BMFcases

Experts Discuss Pros and Cons of Treatment Approaches in PV

Feat. T. Bat, A. Tefferi
27:37
Indy Hematology Review

Review of Myeloproliferative Neoplasms

Feat. A. Tefferi
17:05
BMFcases

Diagnosis and Prognosis in PV: Utility of BM Biopsy, Clinical Findin…

Feat. T. Bat, A. Tefferi
10:02
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "The Best of MPNs - Highlights & Key Take…

Feat. R. Mesa
21:52
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "MF, ET, and PV - Highlights and Clinical Imp…

Feat. D. Tremblay
05:20
Prithviraj Bose

When to Switch From Hydroxyurea to Ruxolitinib in PV

08:11
Krisstina Gowin

Counseling Patients With Newly Diagnosed PV or ET

09:27
ASH 2022 Conference Coverage

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

Feat. M. McMullin
16:25
Northwestern Medicine Oncology and Hematology

Diagnosis and Goals of Therapy in PV

Feat. B. Stein
19:47
Monia Marchetti

CYTO-PV Study: Importance of Hematocrit Control and Early Interventi…

17:51
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Chronic GVHD: A Case-Based Discussion

Feat. L. Perry
16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison
16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison
51:20
Jerry Spivak

Polycythemia Vera: Disease Overview, Treatment Landscape, and Curren…

27:47
City of Hope

Chronic GVHD: Review Advances in Prevention, Novel Endpoints, and Ta…

Feat. I. Amanam
16:52
Winship Cancer Institute - Emory University

Updates on Myeloproliferative Neoplasms Including CML

Feat. A. Hunter
08:49
BMFcases

Experts Address Clinical Questions in PV: Utility of Aspirin, Rusfer…

Feat. T. Bat, A. Tefferi